Reliance Life Sciences Private Limited recalls Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for:
Recalled July 15, 2026 · FDA recall D-0673-2026 · Reliance Life Sciences Private
Hazard
Lack of Sterility Assurance · FDA Class II
Units
11,400 vials
Sold at
Nationwide in the USA
Description
Lack of Sterility Assurance
Product
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Manufacturer(s)
Reliance Life Sciences Private Limited
Made in
India
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →